Fig. 5From: Transarterial chemoembolization (TACE) plus tyrosine kinase inhibitors versus TACE in patients with hepatocellular carcinoma: a systematic review and meta-analysisMeta-analysis for treatment effects of TKIS in combination with TACE on overall survival (OS) in patients with unresectable hepatocellular carcinomaBack to article page